Phase I Study of MK-1775 with Radiation and Temozolomide In Patients with Newly Diagnosed Glioblastoma and Evaluation of lntratumoral Drug Distribution in Patients with Recurrent Glioblastoma

Grant

Date/time Interval

  • November 1, 2013 - December 31, 2019
  • Total Award Amount

  • 12000.00
  • Direct Costs

  • 8164.00
  • Sponsor Award Id

  • ABTC1202
  • Contributor

  • Fathallah-Shaykh M.D., Ph.D., Hassan   Investigator  
  • Han, Xiaosi   Investigator  
  • Maron, Rhodemarie   Investigator  
  • Nabors M.D., Louis   Principal Investigator